Dexcel Pharma logo

Dexcel Pharma

Asia, Yerushalayim, Israel, Jerusalem

Description

Dexcel Pharma is an international specialty pharmaceutical company.

Investor Profile

Dexcel Pharma has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Series A (29%)
  • Private Equity (29%)
  • Series Unknown (14%)
  • Series B (14%)
  • Series C (14%)

Country Focus

  • United States (86%)
  • Israel (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Biopharma
  • Pharmaceutical
  • Product Research
  • Medical
  • Medical Device
  • Analytics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dexcel Pharma frequently co-invest with?

Amplo
North America, Texas, United States, Spring
Co-Investments: 2
Narya Capital
North America, Ohio, United States, Columbus
Co-Investments: 3
Patient Square Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Bluebird Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
CAM Capital
North America, New York, United States, New York
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 3
TC
North America, Michigan, United States, Ann Arbor
Co-Investments: 3
QVT Financial
North America, New York, United States, New York
Co-Investments: 5
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2

Which angels does Dexcel Pharma often collaborate with?

PM
North America, Virginia, United States, Charlottesville
Shared Deals: 1

What are some of recent deals done by Dexcel Pharma?

Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series CMay 16, 2022
Amount Raised: $270,000,000
BrainQ

Jerusalem, Yerushalayim, Israel

BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach.

Health CareMedicalMedical Device
Series UnknownAug 16, 2021
Amount Raised: $40,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series BJul 14, 2021
Amount Raised: $100,000,000
Immunai

New York, New York, United States

Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.

AnalyticsArtificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics
Series AFeb 11, 2021
Amount Raised: $60,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series AMay 12, 2020
Amount Raised: $80,500,000
Roivant Sciences

New York, New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

BiopharmaBiotechnologyHealth CarePharmaceuticalProduct Research
Private EquityNov 13, 2018
Amount Raised: $200,000,000
Roivant Sciences

New York, New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

BiopharmaBiotechnologyHealth CarePharmaceuticalProduct Research
Private EquityMay 1, 2014
Amount Raised: $93,000,000